Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:47 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:00 PM EDT
Entrada Therapeutics Fail-to-Deliver
Total FTD Shares
27K
Below Average
FTD / Avg. Volume
15.40%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Entrada Therapeutics Inc. has
27,000
shares failed to deliver, representing 15.40%
of the average daily volume of
175,343
shares. Over the past year, the monthly average FTD is
4,580
shares, with the current level 490% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 6.8 | 27K | -64.00% |
Jun 30, 2025 | 6.72 | 75K | +48287.10% |
May 01, 2025 | 9.05 | 155 | -93.59% |
Apr 25, 2025 | 8.84 | 2.42K | +7014.71% |
Mar 31, 2025 | 9.04 | 34 | -15.00% |
Feb 24, 2025 | 12.85 | 40 | -94.32% |
Jan 13, 2025 | 13.37 | 704 | +44.56% |
Dec 24, 2024 | 17.56 | 487 | -85.69% |
Nov 26, 2024 | 19.37 | 3.4K | +748.88% |
Oct 30, 2024 | 17.23 | 401 | -78.43% |
Sep 27, 2024 | 16.45 | 1.86K | +125.33% |
Aug 30, 2024 | 17.7 | 825 | -13.34% |
Jul 30, 2024 | 16.9 | 952 | -9.76% |
Jun 14, 2024 | 15.78 | 1.05K | +70.99% |
May 31, 2024 | 15.47 | 617 | +1271.11% |
Apr 25, 2024 | 12.36 | 45 | -97.11% |
Mar 28, 2024 | 14.17 | 1.56K | +333.98% |
Feb 27, 2024 | 13.65 | 359 | -75.14% |
Jan 31, 2024 | 14.57 | 1.44K | -48.04% |
Dec 29, 2023 | 15.09 | 2.78K | +27690.00% |
Nov 30, 2023 | 12.97 | 10 | -96.68% |
Oct 31, 2023 | 16.01 | 301 | -89.01% |
Sep 27, 2023 | 15.5 | 2.74K | +4705.26% |
Aug 14, 2023 | 15.36 | 57 | -96.34% |
Jul 28, 2023 | 17.28 | 1.56K | -77.89% |
Jun 30, 2023 | 15.14 | 7.04K | +2847.70% |
May 31, 2023 | 11.46 | 239 | +1393.75% |
Apr 28, 2023 | 11.71 | 16 | -99.20% |
Mar 29, 2023 | 14.77 | 2K | +136.41% |
Feb 23, 2023 | 11.54 | 846 | +683.33% |
Jan 26, 2023 | 11.67 | 108 | n/a |